company background image

WSI KOSDAQ:A299170 Stock Report

Last Price


Market Cap







15 May, 2022


Company Financials
A299170 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance2/6
Financial Health5/6

A299170 Stock Overview

No business description

WSI Competitors













Price History & Performance

Summary of all time highs, changes and price drops for WSI
Historical stock prices
Current Share Price₩2,530.00
52 Week High₩3,515.00
52 Week Low₩2,285.00
1 Month Change-8.50%
3 Month Change3.69%
1 Year Change-15.67%
3 Year Changen/a
5 Year Changen/a
Change since IPO-26.24%

Recent News & Updates

Shareholder Returns

A299170KR HealthcareKR Market

Return vs Industry: A299170 exceeded the KR Healthcare industry which returned -43.5% over the past year.

Return vs Market: A299170 matched the KR Market which returned -15.2% over the past year.

Price Volatility

Is A299170's price volatile compared to industry and market?
A299170 volatility
A299170 Average Weekly Movement3.5%
Healthcare Industry Average Movement5.7%
Market Average Movement5.6%
10% most volatile stocks in KR Market10.4%
10% least volatile stocks in KR Market3.2%

Stable Share Price: A299170 is less volatile than 75% of KR stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: A299170's weekly volatility (4%) has been stable over the past year.

About the Company


WSI Fundamentals Summary

How do WSI's earnings and revenue compare to its market cap?
A299170 fundamental statistics
Market Cap₩75.97b
Earnings (TTM)₩7.17b
Revenue (TTM)₩27.78b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A299170 income statement (TTM)
Cost of Revenue₩17.59b
Gross Profit₩10.18b
Other Expenses₩3.01b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date


Earnings per share (EPS)238.94
Gross Margin36.66%
Net Profit Margin25.83%
Debt/Equity Ratio21.3%

How did A299170 perform over the long term?

See historical performance and comparison


Is WSI undervalued compared to its fair value and its price relative to the market?

Valuation Score


Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: A299170 (₩2530) is trading below our estimate of fair value (₩17677.38)

Significantly Below Fair Value: A299170 is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: A299170 is good value based on its PE Ratio (10.6x) compared to the Asian Healthcare industry average (18.1x).

PE vs Market: A299170 is good value based on its PE Ratio (10.6x) compared to the KR market (14.2x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate A299170's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: A299170 is overvalued based on its PB Ratio (2.3x) compared to the KR Healthcare industry average (2.2x).

Future Growth

How is WSI forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as WSI has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has WSI performed over the past 5 years?

Past Performance Score


Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Last years revenue growth

Earnings and Revenue History

Quality Earnings: A299170 has a high level of non-cash earnings.

Growing Profit Margin: A299170 became profitable in the past.

Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if A299170's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: A299170 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: A299170 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (34.8%).

Return on Equity

High ROE: A299170's Return on Equity (21.5%) is considered high.

Financial Health

How is WSI's financial position?

Financial Health Score


Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: A299170's short term assets (₩47.6B) exceed its short term liabilities (₩18.0B).

Long Term Liabilities: A299170's short term assets (₩47.6B) exceed its long term liabilities (₩1.1B).

Debt to Equity History and Analysis

Debt Level: A299170 has more cash than its total debt.

Reducing Debt: Insufficient data to determine if A299170's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: A299170's debt is well covered by operating cash flow (83.6%).

Interest Coverage: A299170's interest payments on its debt are well covered by EBIT (12.1x coverage).

Balance Sheet


What is WSI current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate A299170's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A299170's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if A299170's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A299170's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A299170 has not reported any payouts.

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


WSI has no CEO, or we have no data on them.


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.7%.

Top Shareholders

Company Information

WSI Co., Ltd.'s employee growth, exchange listings and data sources

Key Information

  • Name: WSI Co., Ltd.
  • Ticker: A299170
  • Exchange: KOSDAQ
  • Founded: NaN
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Implied Market Cap: ₩75.971b
  • Shares outstanding: 30.03m
  • Website:

Number of Employees


  • WSI Co., Ltd.
  • 365 Hwarang-ro
  • Bangchon-dong, Dong-gu
  • Daegu
  • 41161
  • South Korea


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/15 00:00
End of Day Share Price2022/05/13 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.